Global Anesthesia CO2 Absorbent Market is expected to reach USD
79.1 million by 2022, according to a new report by Grand View Research, Inc.
Rising geriatric population, increasing usage of regional anesthesia, and
augmenting volume of surgical procedures across the globe are vital impact
rendering drivers for the market.
Anesthesia CO2 absorbent forms a niche
segment within the anesthesia disposables, the demand for which is expected to
rise with increasing number of surgeries. According to the statistics provided
by the WHO in collaboration with the Department of Health Policy and Management
of Harvard, the global surgical volume is high and accounts for about 234
million surgeries per year.
Furthermore, with this increase, a proportional rise in
complications and deaths after surgery are being witnessed. According to the
statistics provided by the U.S. Agency for Healthcare Research and Quality, one
in 150 patients dies due to improper administration of anesthesia.
The Harvard School of Public Health’s study links economic
conditions of a country with volume of surgeries and states that prevalence of
major surgeries is 37 times higher in countries with healthcare expenditure
above USD 1,000 per person.
Request to Sample
of This Report @ http://www.grandviewresearch.com/industry-analysis/anesthesia-co2-absorbent-market
Further key findings from the study suggest:
- Amsorb is expected to witness the fastest growth over the forecast period owing to increasing demand for absorbents free from presence of KOH and clarity in exhaustion indication. Amsorb is anticipated to grow at a CAGR of over 10.0% over the next seven years and contribute about 14.0% revenue to the industry.
- Latin America and Asia Pacific are predicted to be the fastest growing regions for the anesthesia CO2 absorbent market. Together, they are expected to hold over 25.0% of the market share by 2022. Strategic reforms in healthcare policies and increasing healthcare spending patterns are expected to be the market drivers within the region.
- Key players of the industry include GE Healthcare, Smiths Medical, CareFusion (Becton Dickinson and Co.), Armstrong Medical, and Drager Medical GmbH. Other players include King Pharmaceuticals, Allied Healthcare Products, Molecular Products, Micropore, and Medisize. GE Healthcare’s vital sign division responsible for manufacturing of anesthesia CO2 absorbent was acquired by CareFusion in 2013, thereby making it a leader for single patient use consumables for anesthesiology.
- Also, cases of patent infringement are being reported by players such as Drager. In October 2015, the company filed a patent infringement lawsuit against Allied Healthcare alleging infringement carbolyme single use carbon dioxide absorption cartridges. This action is anticipated to help the company maintain its market share and control competition.
To Get Sample Copy of Report visit
@ http://www.grandviewresearch.com/industry-analysis/anesthesia-co2-absorbent-market/request
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For More Information,
Visit Grand
View Research
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment